Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies VANCOUVER, British Columbia; Link here – May 3, 2023 – Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-05-29 04:51:082023-05-29 04:51:08Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program
Raven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical Development LA JOLLA, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Link here: CalciMedica Inc. (“CalciMedica”) (OTCQB: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced the appointments of […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-05-29 04:43:522023-05-29 04:43:52CalciMedica Expands Executive Team with New Appointments
Patients with Parkinson’s disease are being given life-changing smart watches that allow doctors to remotely assess their condition in a pioneering project to revolutionise NHS care. NHS chief executive Amanda Pritchard said: “Parkinson’s is an incurable illness that has a significant impact on peoples’ lives and this small watch will dramatically improve their quality of life […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-04-28 04:02:322023-04-28 04:02:32Parkinson’s patients benefit from revolutionary watch on the NHS to manage care at home
Link here: Adherium Limited is pleased to announce that its UK value-add distribution partner, Helicon Health Ltd, has been awarded a prestigious 3 year Fellowship on the 2023 NHS Innovation Accelerator (NIA), to boost their new Director of Operations, Sander Ten Veldhuijs, in scaling the Hailie® Digital Inhaler solution across NHS England. The NIA programme […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-04-28 03:48:412023-04-28 03:48:41Adherium’s UK Partner awarded place on prestigious NHS Innovation Accelerator for Hailie Digital Inhaler
Financing Further Propels Commercial and Research & Development Initiatives Artarmon, NSW & Bloomington, MN – April 13, 2023, Link here – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-04-14 00:05:252023-04-14 00:05:25Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG
Adherium receives U.S. FDA 510(k) clearance for Teva’s ProAir® and Albuterol Sulphate inhaler users to remotely monitor physiological parametersMelbourne, Australia – 23 March 2023, Link Here : Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce that it has received U.S. Food and Drug […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-03-23 22:46:282023-03-23 22:46:28US FDA clearance of Adherium’s Hailie for Teva inhalers
Received Outstanding Achievement in Research for EVOKE Clinical Trial Sustained Superiority of Evoke® Closed-Loop Pain Relief and Improvement in Quality-of-Life Scores at 36-months Artarmon, Australia – March 22, 2023 – Link here – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that the EVOKE 36-month […]
LA JOLLA, Calif., March 20, 2023 (GLOBE NEWSWIRE): News Link – CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC” – Cash and cash equivalents of approximately $34 million as of merger close expected to support operations into the second half of 2024 – Phase 2b results in acute pancreatitis for lead […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-03-20 23:57:102023-03-20 23:57:10CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
Listen to the On the Couch biotech special podcast. Host Henry Jennings sits down with fund manager BioScience Managers and biotechs Biotron and Pharmaxis to discuss what makes a successful biotech and how to invest successfully in the cutting edge of medical science and drug treatments. In this ‘On the Couch’ special, Henry Jennings sits down with two […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-03-20 05:06:062023-03-20 05:06:06MarcusToday On the Couch Podcast: Biotech Special
ASX Release: 23 January 2023 Melbourne, Australia; Acrux Limited (ASX:ACR) Link Here: Acrux today announced that it has concluded an agreement with Gedeon Richter Plc., one of its manufacturing and distribution partners, for Gedeon Richter to buy out the future royalties of Lenzetto® for contracted territories for EUR4.10 million, which at current rates of exchange […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-01-24 23:23:492023-01-24 23:23:49Acrux announces Gedeon Richter buyout of future Lenzetto® royalties for EUR4.1 million
Canary Medical Wins “Healthcare Analytics Innovation Award” in 7th Annual MedTech Breakthrough Award Program
/in Canary MedicalPrestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies VANCOUVER, British Columbia; Link here – May 3, 2023 – Canary Medical, a medical data company focused on the development and commercialization of its patented implantable sensor technology and complementary data and analytics ecosystem, today announced that it has been […]
CalciMedica Expands Executive Team with New Appointments
/in CalcimedicaRaven Jaeger, M.S. named Chief Regulatory Officer and Andrew Cunningham, M.D., MRCPI, named Senior Vice President, Clinical Development LA JOLLA, Calif., May 23, 2023 (GLOBE NEWSWIRE) — Link here: CalciMedica Inc. (“CalciMedica”) (OTCQB: CALC), a clinical-stage biopharmaceutical company focused on developing therapies for life-threatening inflammatory diseases with high unmet need, today announced the appointments of […]
Parkinson’s patients benefit from revolutionary watch on the NHS to manage care at home
/in GKCPatients with Parkinson’s disease are being given life-changing smart watches that allow doctors to remotely assess their condition in a pioneering project to revolutionise NHS care. NHS chief executive Amanda Pritchard said: “Parkinson’s is an incurable illness that has a significant impact on peoples’ lives and this small watch will dramatically improve their quality of life […]
Adherium’s UK Partner awarded place on prestigious NHS Innovation Accelerator for Hailie Digital Inhaler
/in AdheriumLink here: Adherium Limited is pleased to announce that its UK value-add distribution partner, Helicon Health Ltd, has been awarded a prestigious 3 year Fellowship on the 2023 NHS Innovation Accelerator (NIA), to boost their new Director of Operations, Sander Ten Veldhuijs, in scaling the Hailie® Digital Inhaler solution across NHS England. The NIA programme […]
Saluda Medical Announces $150M Equity Financing Led by Wellington Management with Fidelity Management & Research Company and TPG
/in Saluda MedicalFinancing Further Propels Commercial and Research & Development Initiatives Artarmon, NSW & Bloomington, MN – April 13, 2023, Link here – Saluda Medical Inc. (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation with an emerging portfolio of therapies driven by advanced closed-loop technologies designed to treat debilitating neurological disorders, today announced the […]
US FDA clearance of Adherium’s Hailie for Teva inhalers
/in AdheriumAdherium receives U.S. FDA 510(k) clearance for Teva’s ProAir® and Albuterol Sulphate inhaler users to remotely monitor physiological parametersMelbourne, Australia – 23 March 2023, Link Here : Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce that it has received U.S. Food and Drug […]
EVOKE Presentation Awarded Overall Winner at ASIPP Annual Meeting
/in Saluda MedicalReceived Outstanding Achievement in Research for EVOKE Clinical Trial Sustained Superiority of Evoke® Closed-Loop Pain Relief and Improvement in Quality-of-Life Scores at 36-months Artarmon, Australia – March 22, 2023 – Link here – Saluda Medical Pty Limited (“Saluda Medical”), a global medical device company revolutionizing the field of neuromodulation, today announced that the EVOKE 36-month […]
CalciMedica Announces Closing of Merger with Graybug Vision and Concurrent Private Placement
/in CalcimedicaLA JOLLA, Calif., March 20, 2023 (GLOBE NEWSWIRE): News Link – CalciMedica common stock to commence trading on Nasdaq Global Market on March 21, 2023 under ticker symbol “CALC” – Cash and cash equivalents of approximately $34 million as of merger close expected to support operations into the second half of 2024 – Phase 2b results in acute pancreatitis for lead […]
MarcusToday On the Couch Podcast: Biotech Special
/in BioSciences ManagersListen to the On the Couch biotech special podcast. Host Henry Jennings sits down with fund manager BioScience Managers and biotechs Biotron and Pharmaxis to discuss what makes a successful biotech and how to invest successfully in the cutting edge of medical science and drug treatments. In this ‘On the Couch’ special, Henry Jennings sits down with two […]
Acrux announces Gedeon Richter buyout of future Lenzetto® royalties for EUR4.1 million
/in AcruxASX Release: 23 January 2023 Melbourne, Australia; Acrux Limited (ASX:ACR) Link Here: Acrux today announced that it has concluded an agreement with Gedeon Richter Plc., one of its manufacturing and distribution partners, for Gedeon Richter to buy out the future royalties of Lenzetto® for contracted territories for EUR4.10 million, which at current rates of exchange […]